BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


LONDON (Alliance News) - Real time technologies provider BATM Advanced Communications Ltd on Wednesday said it has completed an upgrade of the Carrier...


Tuesday 20 November Pan African ResourcesCap-XXPhysiomicsWednesday 21 22


LONDON (Alliance News) - Technology company BATM Advanced Communications Ltd on Monday proposed the appointment of two new external directors.On Novem...


LONDON (Alliance News) - BATM Advanced Communications Ltd on Tuesday expressed confidence for the reminder of 2018 after its loss narrowed in the firs...


LONDON (Alliance News) - BATM Advanced Communications Ltd said Wednesday it has agreed to sell its stake in a fibre-optic consortium building a networ...


Thursday 31 MayBradyCard Factorye-TherapeuticsFaron 1 US Smaller Co IT (re right 4 by